Mutations, drugs drive cancer by blurring growth signals

ARTICLE PREVIEW

Genetic mutations in a form of non-small cell lung cancer (NSCLC) may drive tumor formation by blurring cells' perception of key growth signals, according to a new laboratory study. The research could have important implications for understanding and ultimately targeting the defective mechanisms underlying many human cancers.

The rest of this article can be found here

https://www.sciencedaily.com/releases/2018/08/180831175032.htm